As per Data Bridge Market Research Analysis the global inflammatory myopathies market size was valued at USD 1.81 billion in 2025 and is expected to reach USD 2.67 billion by 2033, at a CAGR of 5.00% during the forecast period
The market growth is largely fueled by the rising prevalence of autoimmune and rare neuromuscular disorders, increasing awareness regarding early diagnosis of muscle weakness conditions, and continuous advancements in immunosuppressive and biologic therapies, leading to improved disease management and patient outcomes
Furthermore, growing demand for targeted and long-term treatment options, increasing focus on improving muscle function and quality of life, and expanding access to specialized neurology and rheumatology care are establishing Inflammatory Myopathies solutions as an important component of modern rare disease management. These converging factors are accelerating the uptake of Inflammatory Myopathies solutions, thereby significantly boosting the industry's growth